AHA Scientific Sessions 2026 Abstract · Nov 2, 2026
Greater CKM Burden is Independently Associated with Progressive Cardiovascular Risk in High-Risk Hypertensive Adults Without Diabetes: A SPRINT Analysis
By Cheon P, Iyengar S, Mirzai S et al.
Background: The cardiovascular-kidney-metabolic (CKM) framework recognizes the interconnected contributions of metabolic dysfunction, kidney disease, obesity, and subclinical cardiovascular injury to cardiovascular risk. However, the prognostic significance of biomarker-enriched CKM burden among high-risk hypertensive adults without diabetes remains incompletely understood. Research Question: Among high-risk hypertensive adults without diabetes, is a biomarker-enriched measure of CKM burden associated with incident cardiovascular events independent of traditional risk factors? Methods: We performed a secondary analysis of participants in the Systolic Blood Pressure Intervention Trial (SPRINT). CKM burden was defined using four abnormal domains assessed at baseline: metabolic dysfunction (triglyceride-glucose index [TyG] ≥75th percentile), kidney dysfunction (estimated glomerular filtration rate <60 mL/min/1.73m ² and/or urine albumin-creatinine ratio ≥30 mg/g), cardiac injury/stress (high-sensitivity troponin I ≥14 ng/L and/or NT-proBNP ≥125 pg/mL), and obesity (body mass index ≥30 kg/m ² ). Participants were categorized according to the number of abnormal CKM domains (0, 1, 2, 3, or 4). The primary outcome was the SPRINT primary cardiovascular composite outcome. Fine-Gray competing-risk models accounting for non-cardiovascular death were used to evaluate associations between CKM burden and outcomes after multivariable adjustment. Results: Among 8,696 participants included in the analysis, mean age was 67.9 years, 36.8% were women, and 57.9% were White. Over a median follow-up of 3.8 years, 680 primary outcome events occurred. CKM burden was common, with 16.1%, 34.1%, 33.5%, 13.7%, and 2.6% of participants having 0, 1, 2, 3, and 4 abnormal CKM domains, respectively. Compared with participants with no abnormal CKM domains, higher CKM burden was associated with progressively increased risk of the primary outcome in adjusted competing-risk models. Subdistribution hazard ratios (sHRs) were 1.65 (95% CI 1.20-2.27) for 1 abnormal domain, 2.40 (95% CI 1.76-3.27) for 2 abnormal domains, 3.26 (95% CI 2.34-4.55) for 3 abnormal domains, and 3.91 (95% CI 2.52-6.05) for 4 abnormal domains (P-trend <0.001) (Table) . Conclusions: Among high-risk hypertensive adults without diabetes, increasing burden of abnormal CKM domains was independently associated with progressively higher cardiovascular risk. These findings support the prognostic relevance of cumulative CKM abnormalities in high-risk hypertensive adults without diabetes and warrant further investigation to determine whether integrated CKM burden assessment improves risk prediction and informs treatment intensification.